Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMP | P19971 | 7/20 | 0.53 |
| ▸ | ADORA1 | P30542 | 5/20 | 0.46 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.46 |
| ▸ | ADORA2A | P29274 | 3/20 | 0.46 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.46 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.45 |
| ▸ | DNPH1 | O43598 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6898807 | 0.94 | TYMP (0.55) | TYMPADORA1ADORA2AADORA2BP2RY12 | |
| SCHEMBL6894664 | 0.93 | TYMP (0.54) | TYMPADORA1P2RY12 | |
| SCHEMBL6896830 | 0.93 | TYMP (0.55) | TYMPADORA1ADORA2AADORA2BP2RY12 | |
| SCHEMBL1040958 | 0.93 | TYMP (0.56) | TYMPADORA1ADORA2AADORA2BP2RY12 | |
| SCHEMBL30200670 | 0.93 | TYMP (0.56) | TYMPADORA1ADORA2AADORA2BP2RY12 | |
| SCHEMBL6834984 | 0.93 | TYMP (0.56) | TYMPADORA1ADORA2AADORA2BP2RY12 | |
| SCHEMBL4464744 | 0.92 | TYMP (0.53) | TYMPADORA1P2RY12 | |
| SCHEMBL6899475 | 0.92 | TYMP (0.56) | TYMPADORA1ADORA2AADORA2BP2RY12 | |
| SCHEMBL6900160 | 0.91 | TYMP (0.56) | TYMPADORA1ADORA2AADORA2BP2RY12 | |
| SCHEMBL23650062 | 0.91 | TYMP (0.58) | TYMPADORA1ADORA2AADORA2BP2RY12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0604409-B1 | OLIGONUCLEOTIDE ANALOGS FOR DETECTING AND MODULATING RNA ACTIVITY AND GENE EXPRESSION | ISIS PHARMACEUTICALS INC (US) | 2004-07-14 | — | — | EP | disclosed |
| EP-1418179-A2 | Compositions and methods for detecting and modulating rna activity and gene expression | ISIS PHARMACEUTICALS, INC. (US) | 2004-05-12 | — | — | EP | disclosed |
| US-6262241-B1 | ANTISENSE COMPOUNDS WHICH CLEAVE PHOSPHORODIESTER BONDS AND IMPROVE PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES OF OLIGONUCLEOTIDES, USEFUL IN DIAGNOSING DISEASES | ISIS PHARMACEUTICALS, INC. | 2001-07-17 | — | — | US | disclosed |